{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:43:13Z","timestamp":1792456993304,"version":"4.5.0"},"reference-count":59,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>RNA transfection of dendritic cells (DCs) was shown to be highly efficient in eliciting CD8+ and CD4+ T-cell responses. However, antigen presentation pathways involved in generation of human leukocyte antigen (HLA) class I and class II peptides have remained elusive. To analyze this we incubated mucin 1 (MUC1) RNA-transfected DCs with compounds known to inhibit HLA class I presentation and used these cells in chromium 51 (51Cr)\u2013release assays. As effectors, we used cytotoxic T lymphocyte (CTL) lines specific for the MUC1 peptides M1.1 and M1.2. We observed that the presentation of HLA-A*02 epitopes is inhibited by brefeldin A and lactacystin. To determine the requirement of a functional transporter associated with antigen processing (TAP), we cotransfected DCs with MUC1 and infected cell peptide 47 (ICP47) RNA. ICP47 could only inhibit the presentation of the M1.1 but not the M1.2 peptide, indicating that this epitope derived from the signal sequence is presented independently of TAP. Cocultivation of MUC1 RNA-transfected DCs with MUC1-specific CD4+ T lymphocytes revealed that the presentation of HLA class II peptides is sensitive to proteasomal inhibitors and brefeldin A. Furthermore, the presentation pathway requires lysosomal and endosomal processing and is mediated by autophagy. Our results demonstrate that the efficient presentation of cytosolic proteins on major histocompatibility complex (MHC) class II combines the proteolytic and lysosomal pathways.<\/jats:p>","DOI":"10.1182\/blood-2004-09-3556","type":"journal-article","created":{"date-parts":[[2004,12,24]],"date-time":"2004-12-24T02:34:49Z","timestamp":1103855689000},"page":"3199-3205","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":143,"title":["Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro\u2013transcribed MUC1 RNA"],"prefix":"10.1182","volume":"105","author":[{"given":"Daniela","family":"Do\u0308rfel","sequence":"first","affiliation":[{"name":"From the Department of Hematology, Oncology and Immunology, University of Tu\u0308bingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Appel","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Oncology and Immunology, University of Tu\u0308bingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Gru\u0308nebach","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Oncology and Immunology, University of Tu\u0308bingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus M.","family":"Weck","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Oncology and Immunology, University of Tu\u0308bingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Mu\u0308ller","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Oncology and Immunology, University of Tu\u0308bingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annkristin","family":"Heine","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Oncology and Immunology, University of Tu\u0308bingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Brossart","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Oncology and Immunology, University of Tu\u0308bingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218365497800_REF1","doi-asserted-by":"crossref","unstructured":"Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000; 18:767-811.","DOI":"10.1146\/annurev.immunol.18.1.767"},{"key":"2020021218365497800_","doi-asserted-by":"crossref","unstructured":"Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol. 1997;9:10-16.","DOI":"10.1016\/S0952-7915(97)80153-7"},{"key":"2020021218365497800_REF3","doi-asserted-by":"crossref","unstructured":"Nencioni A, Brossart P. Cellular immunotherapy with dendritic cells in cancer: current status. Stem Cells. 2004;22:501-513.","DOI":"10.1634\/stemcells.22-4-501"},{"key":"2020021218365497800_REF4","doi-asserted-by":"crossref","unstructured":"Boczkowski D, Nair SK, Snyder D, Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med. 1996;184:465-472.","DOI":"10.1084\/jem.184.2.465"},{"key":"2020021218365497800_","unstructured":"Su Z, Dannull J, Heiser A, et al. Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells. Cancer Res. 2003;63:2127-2133."},{"key":"2020021218365497800_","doi-asserted-by":"crossref","unstructured":"Heiser A, Dahm P, Yancey DR, et al. Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro. J Immunol. 2000;164:5508-5514.","DOI":"10.4049\/jimmunol.164.10.5508"},{"key":"2020021218365497800_","doi-asserted-by":"crossref","unstructured":"Nair SK, Heiser A, Boczkowski D, et al. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat Med. 2000;6:1011-1017.","DOI":"10.1038\/79519"},{"key":"2020021218365497800_REF8","doi-asserted-by":"crossref","unstructured":"Milazzo C, Reichardt VL, Muller MR, Grunebach F, Brossart P. Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA. Blood. 2003;101:977-982.","DOI":"10.1182\/blood-2002-04-1273"},{"key":"2020021218365497800_REF9","doi-asserted-by":"crossref","unstructured":"Muller MR, Grunebach F, Nencioni A, Brossart P. Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes. J Immunol. 2003;170:5892-5896.","DOI":"10.4049\/jimmunol.170.12.5892"},{"key":"2020021218365497800_","doi-asserted-by":"crossref","unstructured":"Muller MR, Tsakou G, Grunebach F, Schmidt SM, Brossart P. Induction of chronic lymphocytic leukemia (CLL)-specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells. Blood. 2004;103:1763-1769.","DOI":"10.1182\/blood-2003-06-2097"},{"key":"2020021218365497800_","doi-asserted-by":"crossref","unstructured":"Weissman D, Ni H, Scales D, et al. HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response. J Immunol. 2000;165:4710-4717.","DOI":"10.4049\/jimmunol.165.8.4710"},{"key":"2020021218365497800_REF12","unstructured":"Su Z, Vieweg J, Weizer AZ, et al. Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product. Cancer Res. 2002; 62:5041-5048."},{"key":"2020021218365497800_REF13","doi-asserted-by":"crossref","unstructured":"Kalams SA, Walker BD. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med. 1998;188:2199-2204.","DOI":"10.1084\/jem.188.12.2199"},{"key":"2020021218365497800_REF14","doi-asserted-by":"crossref","unstructured":"Harding CV. Class II antigen processing: analysis of compartments and functions. Crit Rev Immunol. 1996;16:13-29.","DOI":"10.1615\/CritRevImmunol.v16.i1.20"},{"key":"2020021218365497800_REF15","doi-asserted-by":"crossref","unstructured":"Rudensky AY, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA Jr. Sequence analysis of peptides bound to MHC class II molecules. Nature. 1991;353:622-627.","DOI":"10.1038\/353622a0"},{"key":"2020021218365497800_","doi-asserted-by":"crossref","unstructured":"Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JL. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med. 1993;178:27-47.","DOI":"10.1084\/jem.178.1.27"},{"key":"2020021218365497800_REF17","doi-asserted-by":"crossref","unstructured":"Sant AJ. Endogenous antigen presentation by MHC class II molecules. Immunol Res. 1994;13:253-267.","DOI":"10.1007\/BF02935617"},{"key":"2020021218365497800_REF18","doi-asserted-by":"crossref","unstructured":"Loss GE Jr, Elias CG, Fields PE, Ribaudo RK, McKisic M, Sant AJ. Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways. J Exp Med. 1993;178:73-85.","DOI":"10.1084\/jem.178.1.73"},{"key":"2020021218365497800_","doi-asserted-by":"crossref","unstructured":"Malnati MS, Marti M, LaVaute T, et al. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells. Nature. 1992;357:702-704.","DOI":"10.1038\/357702a0"},{"key":"2020021218365497800_","doi-asserted-by":"crossref","unstructured":"Nimmerjahn F, Kobelt D, Steinkasserer A, et al. Efficient generation and expansion of antigen-specific CD4+ T cells by recombinant influenza viruses. Eur J Immunol. 2003;33:3331-3341.","DOI":"10.1002\/eji.200324342"},{"key":"2020021218365497800_REF21","doi-asserted-by":"crossref","unstructured":"Lechler R, Aichinger G, Lightstone L. The endogenous pathway of MHC class II antigen presentation. Immunol Rev. 1996;151:51-79.","DOI":"10.1111\/j.1600-065X.1996.tb00703.x"},{"key":"2020021218365497800_REF22","doi-asserted-by":"crossref","unstructured":"Lich JD, Elliott JF, Blum JS. Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins. J Exp Med. 2000;191:1513-1524.","DOI":"10.1084\/jem.191.9.1513"},{"key":"2020021218365497800_REF23","doi-asserted-by":"crossref","unstructured":"Nimmerjahn F, Milosevic S, Behrends U, et al. Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy. Eur J Immunol. 2003;33:1250-1259.","DOI":"10.1002\/eji.200323730"},{"key":"2020021218365497800_REF24","unstructured":"Brossart P, Schneider A, Dill P, et al. The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. Cancer Res. 2001;61:6846-6850."},{"key":"2020021218365497800_REF25","doi-asserted-by":"crossref","unstructured":"Brossart P, Heinrich KS, Stuhler G, et al. Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies. Blood. 1999;93:4309-4317.","DOI":"10.1182\/blood.V93.12.4309"},{"key":"2020021218365497800_REF26","doi-asserted-by":"crossref","unstructured":"Van Tendeloo VF, Ponsaerts P, Lardon F, et al. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood. 2001;98:49-56.","DOI":"10.1182\/blood.V98.1.49"},{"key":"2020021218365497800_REF27","doi-asserted-by":"crossref","unstructured":"Grunebach F, Muller MR, Nencioni A, Brossart P. Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes. Gene Ther. 2003;10:367-374.","DOI":"10.1038\/sj.gt.3301901"},{"key":"2020021218365497800_REF28","doi-asserted-by":"crossref","unstructured":"Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, et al. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem. 1990;265:15286-15293.","DOI":"10.1016\/S0021-9258(18)77254-2"},{"key":"2020021218365497800_REF29","doi-asserted-by":"crossref","unstructured":"Rock KL, Gramm C, Rothstein L, et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 1994;78:761-771.","DOI":"10.1016\/S0092-8674(94)90462-6"},{"key":"2020021218365497800_REF30","doi-asserted-by":"crossref","unstructured":"Craiu A, Gaczynska M, Akopian T, et al. Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J Biol Chem. 1997;272:13437-13445.","DOI":"10.1074\/jbc.272.20.13437"},{"key":"2020021218365497800_","doi-asserted-by":"crossref","unstructured":"Fenteany G, Schreiber SL. Lactacystin, proteasome function, and cell fate. J Biol Chem. 1998; 273:8545-8548.","DOI":"10.1074\/jbc.273.15.8545"},{"key":"2020021218365497800_REF32","doi-asserted-by":"crossref","unstructured":"Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science. 1995;268:726-731.","DOI":"10.1126\/science.7732382"},{"key":"2020021218365497800_REF33","doi-asserted-by":"crossref","unstructured":"Rotzschke O, Falk K, Deres K, et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature. 1990; 348:252-254.","DOI":"10.1038\/348252a0"},{"key":"2020021218365497800_REF34","doi-asserted-by":"crossref","unstructured":"Madden DR, Gorga JC, Strominger JL, Wiley DC. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature. 1991;353:321-325.","DOI":"10.1038\/353321a0"},{"key":"2020021218365497800_REF35","doi-asserted-by":"crossref","unstructured":"Dinter A, Berger EG. Golgi-disturbing agents. Histochem Cell Biol. 1998;109:571-590.","DOI":"10.1007\/s004180050256"},{"key":"2020021218365497800_REF36","doi-asserted-by":"crossref","unstructured":"Pelham HR. Multiple targets for brefeldin A. Cell. 1991;67:449-451.","DOI":"10.1016\/0092-8674(91)90517-3"},{"key":"2020021218365497800_REF37","doi-asserted-by":"crossref","unstructured":"Yewdell JW, Norbury CC, Bennink JR. Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. Adv Immunol. 1999;73:1-77.","DOI":"10.1016\/S0065-2776(08)60785-3"},{"key":"2020021218365497800_REF38","doi-asserted-by":"crossref","unstructured":"Bauer D, Tampe R. Herpes viral proteins blocking the transporter associated with antigen processing TAP\u2014from genes to function and structure. Curr Top Microbiol Immunol. 2002;269:87-99.","DOI":"10.1007\/978-3-642-59421-2_6"},{"key":"2020021218365497800_","doi-asserted-by":"crossref","unstructured":"Ahn K, Meyer TH, Uebel S, et al. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 1996;15:3247-3255.","DOI":"10.1002\/j.1460-2075.1996.tb00689.x"},{"key":"2020021218365497800_REF40","doi-asserted-by":"crossref","unstructured":"Reits E, Griekspoor A, Neefjes J. Herpes viral proteins manipulating the peptide transporter TAP. Curr Top Microbiol Immunol. 2002;269:75-83.","DOI":"10.1007\/978-3-642-59421-2_5"},{"key":"2020021218365497800_REF41","doi-asserted-by":"crossref","unstructured":"Snyder HL, Yewdell JW, Bennink JR. Trimming of antigenic peptides in an early secretory compartment. J Exp Med. 1994;180:2389-2394.","DOI":"10.1084\/jem.180.6.2389"},{"key":"2020021218365497800_REF42","doi-asserted-by":"crossref","unstructured":"Wei ML, Cresswell P. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature. 1992;356:443-446.","DOI":"10.1038\/356443a0"},{"key":"2020021218365497800_REF43","doi-asserted-by":"crossref","unstructured":"Dick LR, Cruikshank AA, Grenier L, Melandri FD, Nunes SL, Stein RL. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone. J Biol Chem. 1996;271:7273-7276.","DOI":"10.1074\/jbc.271.13.7273"},{"key":"2020021218365497800_REF44","doi-asserted-by":"crossref","unstructured":"Sasaki T, Kishi M, Saito M, et al. Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins. J Enzyme Inhib. 1990;3:195-201.","DOI":"10.3109\/14756369009035837"},{"key":"2020021218365497800_REF45","doi-asserted-by":"crossref","unstructured":"Sherwood SW, Kung AL, Roitelman J, Simoni RD, Schimke RT. In vivo inhibition of cyclin B degradation and induction of cell-cycle arrest in mammalian cells by the neutral cysteine protease inhibitor N-acetylleucylleucylnorleucinal. Proc Natl Acad Sci U S A. 1993;90:3353-3357.","DOI":"10.1073\/pnas.90.8.3353"},{"key":"2020021218365497800_REF46","doi-asserted-by":"crossref","unstructured":"Hoffman L, Rechsteiner M. Nucleotidase activities of the 26 S proteasome and its regulatory complex. J Biol Chem. 1996;271:32538-32545.","DOI":"10.1074\/jbc.271.51.32538"},{"key":"2020021218365497800_REF47","doi-asserted-by":"crossref","unstructured":"Reits EA, Vos JC, Gromme M, Neefjes J. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature. 2000;404:774-778.","DOI":"10.1038\/35008103"},{"key":"2020021218365497800_REF48","doi-asserted-by":"crossref","unstructured":"Pinet V, Malnati MS, Long EO. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. J Immunol. 1994;152:4852-4860.","DOI":"10.4049\/jimmunol.152.10.4852"},{"key":"2020021218365497800_REF49","doi-asserted-by":"crossref","unstructured":"McConnell RM, York JL, Frizzell D, Ezell C. Inhibition studies of some serine and thiol proteinases by new leupeptin analogues. J Med Chem. 1993;36:1084-1089.","DOI":"10.1021\/jm00060a016"},{"key":"2020021218365497800_REF50","unstructured":"Powis G, Bonjouklian R, Berggren MM, et al. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 1994; 54:2419-2423."},{"key":"2020021218365497800_REF51","doi-asserted-by":"crossref","unstructured":"Klionsky DJ, Ohsumi Y. Vacuolar import of proteins and organelles from the cytoplasm. Annu Rev Cell Dev Biol. 1999;15:1-32.","DOI":"10.1146\/annurev.cellbio.15.1.1"},{"key":"2020021218365497800_REF52","doi-asserted-by":"crossref","unstructured":"Wymann MP, Bulgarelli-Leva G, Zvelebil MJ, et al. Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol Cell Biol. 1996;16:1722-1733.","DOI":"10.1128\/MCB.16.4.1722"},{"key":"2020021218365497800_REF53","doi-asserted-by":"crossref","unstructured":"Blommaart EF, Krause U, Schellens JP, Vreeling-Sindelarova H, Meijer AJ. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur J Biochem. 1997;243:240-246.","DOI":"10.1111\/j.1432-1033.1997.0240a.x"},{"key":"2020021218365497800_REF54","doi-asserted-by":"crossref","unstructured":"Lautscham G, Rickinson A, Blake N. TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus. Microbes Infect. 2003;5:291-299.","DOI":"10.1016\/S1286-4579(03)00031-5"},{"key":"2020021218365497800_REF55","doi-asserted-by":"crossref","unstructured":"Lautscham G, Mayrhofer S, Taylor G, et al. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway. J Exp Med. 2001;194:1053-1068.","DOI":"10.1084\/jem.194.8.1053"},{"key":"2020021218365497800_REF56","doi-asserted-by":"crossref","unstructured":"Brossart P, Bevan MJ. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood. 1997;90:1594-1599.","DOI":"10.1182\/blood.V90.4.1594"},{"key":"2020021218365497800_REF57","doi-asserted-by":"crossref","unstructured":"Munafo DB, Colombo MI. A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. J Cell Sci. 2001; 114:3619-3629.","DOI":"10.1242\/jcs.114.20.3619"},{"key":"2020021218365497800_REF58","doi-asserted-by":"crossref","unstructured":"Mortimore GE, Miotto G, Venerando R, Kadowaki M. Autophagy. Subcell Biochem. 1996;27:93-135.","DOI":"10.1007\/978-1-4615-5833-0_4"},{"key":"2020021218365497800_REF59","doi-asserted-by":"crossref","unstructured":"Seglen PO, Gordon PB. 3-Methyladenine: specific inhibitor of autophagic\/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A. 1982;79:1889-1892.","DOI":"10.1073\/pnas.79.6.1889"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/8\/3199\/1709240\/zh800805003199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/8\/3199\/1709240\/zh800805003199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T02:43:34Z","timestamp":1682909014000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/8\/3199\/20571\/Processing-and-presentation-of-HLA-class-I-and-II"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,15]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,4,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-09-3556","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,15]]}}}